Differentiated Thyroid Cancer Is Associated With Sex-specific Immune Response.

[BACKGROUND] Thyroid cancer (TC) exhibits sex-based disparities in incidence, progression, and outcomes, with women of reproductive age exhibiting more favorable prognoses than men. This study investigates sex differences in immune cell dynamics within peripheral blood and the tumor microenvironment (TME) in TC.

[METHODS] We performed a prospective study of 27 patients (16 females/11 males) undergoing thyroidectomy for TC or high-risk thyroid nodules. Tissue and blood were collected for immune cell analysis using flow cytometry and spatial transcriptomics. Differential-expression of immune-related genes was assessed with DESeq2, and immune cell frequencies were compared between sexes.

[RESULTS] Males showed higher frequencies of dividing natural killer (NK) cells (9.67 vs 1.29, < .001) and T-cell immunoreceptor with Ig and ITIM domains (Tigit) + CD8 T cells (2.34 vs 0.87, = .04) in the TME. In contrast, females tended to have higher frequencies of mature NK (2.5 vs 1.08, = .07) and CD8 T-cells (0.95 vs 0.68, = .09). Spatial transcriptomics revealed that men had reduced expression of ( = .001, antigen presentation) in both surrounding normal tissue and the tumor border and a trend for increased ( = .09) in normal tissue compared to women. In the core of the tumor, we observed increased ( = .04), ( = .04), and ( = .02) in men vs women.

[CONCLUSION] Our study reveals significant sex-based differences in immune cell composition and gene expression within the TME of TC. Males exhibit a more immunosuppressive profile, with higher levels of inhibitory immune markers and lower frequencies of functional NK cells. Our findings highlight the importance of incorporating sex-specific immune profiles into development of targeted therapies for advanced TC.